Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Completed

Phase 3 Results

Eligibility Criteria

Men and women hypertensive patients, ages 55 and above. A total of 36 percent were diabetics.